Concomitant hypertension in hypertrophic cardiomyopathy: cardiovascular magnetic resonance biomarkers to guide cardiovascular prevention
Although hypertension is present in 25–50% of patients with hypertrophic cardiomyopathy (HCM), its clinical characterization and prognostic implications in this population remain insufficiently investigated.(1) To describe the phenotype of hypertensive patients with HCM using cardiovascular magnetic resona...